TRILAFON Drug Patent Profile
✉ Email this page to a colleague
When do Trilafon patents expire, and when can generic versions of Trilafon launch?
Trilafon is a drug marketed by Schering and is included in five NDAs.
The generic ingredient in TRILAFON is perphenazine. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the perphenazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trilafon
A generic version of TRILAFON was approved as perphenazine by SANDOZ on December 8th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRILAFON?
- What are the global sales for TRILAFON?
- What is Average Wholesale Price for TRILAFON?
Summary for TRILAFON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,665 |
| DailyMed Link: | TRILAFON at DailyMed |
Recent Clinical Trials for TRILAFON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 4 |
| Sunovion | Phase 4 |
| National Institute of Mental Health (NIMH) | Phase 4 |
US Patents and Regulatory Information for TRILAFON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TRILAFON | perphenazine | CONCENTRATE;ORAL | 011557-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | TRILAFON | perphenazine | TABLET;ORAL | 010775-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | TRILAFON | perphenazine | TABLET, EXTENDED RELEASE;ORAL | 011361-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
